Biotech Finds Mid-Week Success Following Q4 Earnings Release
13 Março 2024 - 5:25PM
AllPennyStocks.com
A California-based biotech company saw its
shares soar on Wednesday, a day following the company’s Q4 earnings
announcement. With analysts expecting a net loss of $0.16
per...
To read the full story on AllPennyStocks.com, click
here.
Heron Therapeautics (NASDAQ:HRTX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Heron Therapeautics (NASDAQ:HRTX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024